|
WO2020212650A1
|
|
Method for predicting response to treatment with tyrosine kinase inhibitors and related methods
|
|
WO2020174124A1
|
|
A lighting device
|
|
US2020109332A1
|
|
Synthetic material for detecting ultraviolet radiation and/or X-radiation
|
|
AU2019276749A1
|
|
L1TD1 as predictive biomarker of colon cancer
|
|
WO2019215394A1
|
|
Arpp19 as biomarker for haematological cancers
|
|
FI20195357A1
|
|
Method for fabricating a film
|
|
FI128462B
|
|
Semiconductor structure and method
|
|
WO2019166701A1
|
|
Anti-adenosine signaling pathway antibodies conjugated or fused with adenosine deaminase or capable of binding adenosine deaminase
|
|
FI20195009A1
|
|
An apparatus for measuring functionality of an arterial system
|
|
US2020354434A1
|
|
A novel cip2a variant and uses thereof
|
|
US2020264192A1
|
|
Interleukin 32 as a biomarker of type 1 diabetes
|
|
CA3018859A1
|
|
Treatment of her2-dependent cancers by sorl1 inhibition
|
|
CN112074558A
|
|
Method for preparing PEDOT film
|
|
WO2018087432A1
|
|
A lens array for an optical instrument
|
|
FI20175993A1
|
|
Indicating the intensity of a predetermined type of radiation
|
|
FI20175992A1
|
|
Determining the amount of a predetermined type of radiation irradiated on a sensor material
|
|
WO2018011474A1
|
|
Lectin-based diagnostics of cancers
|
|
FI20175587A
|
|
Silicon-on-insulator with crystalline silicon oxide
|
|
CA3025089A1
|
|
Determination of genetic predisposition to aggressive prostate cancer
|
|
AU2016378819A1
|
|
Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
|
